Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.

Biotechnology

Therapeutics

Asgard Therapeutics

This department oversees the strategic direction and overall operations of the organization.

Executive Leadership

This department oversees the strategic direction and governance of the organization through board leadership and member collaboration.

Board Governance

This department provides expert guidance and strategic advice to stakeholders and decision-makers.

Advisory Services

The Research and Development team at Asgard Therapeutics focuses on advancing innovative gene therapy techniques, specifically utilizing TrojanDC technology to enhance cancer immunotherapy. With a diverse skill set that includes expertise in cell reprogramming and preclinical pharmacology, the team collaborates on designing and executing experimental protocols, analyzing data, and translating findings into clinical applications to improve immune responses against cancer.

Research and Development

This department conducts comprehensive studies and analysis to drive innovation and inform decision-making.

��

People (4)

Jobs (0)

Other teams

Board Governance

Advisory Services

Research and Development

Research Department

��������

People (4)

Jobs (0)

Other teams

Board Governance

Advisory Services

Research and Development

Research Department

��